The BioNTech co-founder said that even though the highly mutated variant could result in more vaccinated people becoming infected, the virus would probably be targeted by immune cells. Photo: PA
The BioNTech co-founder said that even though the highly mutated variant could result in more vaccinated people becoming infected, the virus would probably be targeted by immune cells. Photo: PA